
|Videos|July 3, 2015
What is the Future of Biosimilars?
Author(s)Davy James, Managing Editor
CEO of Avella Specialty Pharmacy Rebecca M. Shanahan, Esq., discusses how specialty pharmacies can best manage the rising cost of specialty drugs to improve outcomes for patients.
Advertisement
CEO of Avella Specialty Pharmacy Rebecca M. Shanahan, Esq., discusses how specialty pharmacies can best manage the rising cost of specialty drugs to improve outcomes for patients.
Newsletter
Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Pharmacy Times
1
Regular Melatonin Supplementation May Hide Hidden Heart Complications
2
CDC Adolescents, Children, & Adult Immunization Schedule: 2025 Update
3
MFN, DTC, and the Policy Pressure Cooker: Reshaping the US Drug Market
4
PCV21-Unique Serotypes Most Prevalent in US Adults With Pneumococcal Disease
5














































































































































































































